Navigation Links
Depomed To Present At Morgan Stanley 2014 Global Healthcare Conference
Date:8/25/2014

NEWARK, Calif., Aug. 25, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will be presenting at the Morgan Stanley 2014 Global Healthcare Conference in New York City.

The presentation at the Morgan Stanley conference is scheduled for 2:40 pm ET (11:40 am PT) on Wednesday September 10, 2014. The presentation will be webcast, and the webcast can be accessed via the Investor Relations page of the Depomed website at www.depomed.com. A recording of the webcast will be archived for 30 days on the company's website.

About Depomed 
Depomed is a specialty pharmaceutical company that commercializes products for pain and CNS disorders. Gralise® (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia. CAMBIA® (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks with or without aura in adults (18 years of age or older). Zipsor® (diclofenac potassium) Liquid Filled Capsules is a non-steroidal anti-inflammatory drug indicated for relief of mild to moderate acute pain in adults. Lazanda® (fentanyl) Nasal Spray is an intranasal fentanyl drug used to manage breakthrough pain in adults (18 years of age or older) who are already routinely taking other opioid pain medicines around-the-clock for cancer pain. Gralise and various partner product candidates are formulated with Depomed's proven, proprietary Acuform® drug delivery technology. Additional information about Depomed may be found at www.depomed.com.

INVESTOR CONTACT:
August J. Moretti  
Depomed, Inc. 510.744.8000
amoretti@depomed.com


'/>"/>
SOURCE Depomed, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Depomed Reports Second Quarter 2014 Financial Results
2. Depomed Announces Appointment of R. Scott Shively as Chief Commercial Officer
3. Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014
4. Depomed Announces District Court Order in ANDA Litigation
5. Depomed Announces Appointment of Srinivas G. Rao, MD, PhD, as Chief Medical Officer
6. Depomed To Present At Piper Jaffray 2013 Healthcare Conference
7. Depomed Reports Third Quarter 2013 Financial Results
8. Depomed To Report Third Quarter Fiscal Year 2013 Financial Results On Tuesday, November 5, 2013
9. Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
10. PDL BioPharma Acquires Portfolio of Diabetes Royalty Rights and Milestones from Depomed
11. Depomed Expands Geographic Scope of License Agreement with Merck for Extended Release Metformin Patents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... PUNE, India , May 25, 2016 /PRNewswire/ ... Pipeline Review, H1 2016"market research report that provides ... complete with comparative analysis at various stages, therapeutics ... route of administration (RoA) and molecule type, along ... releases. It also reviews key players involved in ...
(Date:5/24/2016)... 24, 2016   ... primären Endpunkte und demonstriert Ebenbürtigkeit bei ... ‚ausgezeichneter plus guter , ...      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ) ... positive Daten von der MORA-Studie der Phase III ...
(Date:5/24/2016)... ARANZ Medical  Ltd a specialist ... has been named the Coretex Hi-Tech Emerging Company of the ... Dr Bruce Davey , CEO of ARANZ Medical says, ... good to be recognised for the work we are doing ... in 35 countries around the world from Sub-Saharan Africa through ...
Breaking Medicine Technology:
(Date:5/26/2016)... ... May 26, 2016 , ... In 1980, Bill Howe opened ... throughout the beach community. His vision to grow the company was built on a ... maintain the highest level of training and customer service. Over 35 years later, Bill ...
(Date:5/26/2016)... ... May 26, 2016 , ... Women’s athletic apparel company ... second pop-up shop for three consecutive weekends. The pop-up shop is a great ... community, a community full of women who appreciate the most premium goods and ...
(Date:5/25/2016)... ... May 26, 2016 , ... The 12th session of the Silicon ... at HP in Palo Alto, CA. This Bay Area biotech event will focus on ... trial experts from the pharmaceutical company Hallux, biopharma Apexigen, Contract Research Organization (CRO) Experien ...
(Date:5/25/2016)... ... May 25, 2016 , ... Furthering its position as ... The National Center for Drug Free Sport (Drug Free Sport®) is excited to expand ... to be held July 12 – 13 in Kansas City, MO, will gather sports ...
(Date:5/25/2016)... ... 25, 2016 , ... One Florida-based plastic surgeon’s enthusiasm is proving to be ... published May 13th on Vanity Fair. In fact, as the article explains, more ... broadcast to more than 800,000 Snapchat fans. Commenting on this trend, Dr. Michael Salzhauer, ...
Breaking Medicine News(10 mins):